IN RE: GENERIC PHARMACEUTICALS PRICING ANTITRUST LITIGATION

Track this case

Case Number:

2:16-md-02724

Court:

Pennsylvania Eastern

Nature of Suit:

Other Statutes: Anti-Trust

Multi Party Litigation:

Class Action, Multi-district Litigation

Judge:

CYNTHIA M. RUFE

Firms

Companies

Government Agencies

Sectors & Industries:

August 17, 2023
DOJ Wants Equal Access To Docs in Ex-Exec's Criminal Case

The U.S. Department of Justice has urged a Pennsylvania federal judge to deny a former Taro Pharmaceutical executive's bid to use material from multidistrict litigation over alleged generic drug price-fixing to defend himself in a related criminal case, arguing the request would create an unfair advantage since the court previously rejected a similar ask from the government.
May 23, 2023
DOJ, Drug Buyers Rip Teva's Criminal Probe Doc Bid In MDL

The government and drug buyers fired back in separate filings in Pennsylvania federal court Tuesday against Teva's bid to use material from a criminal investigation into alleged generic drug price-fixing to defend itself in parallel civil multidistrict litigation over similar allegations, arguing it would undermine prosecutions and create a procedural "mess."
March 20, 2023
DOJ Defends Ask For Docs From Drug Price-Fixing MDL

The U.S. Department of Justice defended its bid for discovery materials from multidistrict litigation over generic drug price-fixing claims for use in the government's related criminal prosecutions, rejecting the pharmaceutical companies' claims that the DOJ wanted "unfettered access."
March 13, 2023
Pharma Cos. Say Civil Evidence Off Limits In Criminal Case

Pharmaceutical companies that have been facing multidistrict litigation over price-fixing claims are saying absolutely not to an attempt by the U.S. Department of Justice to access civil discovery materials for use in criminal prosecutions tied to the alleged scheme.
March 10, 2023
Generic Drug Buyers Get $75M In Price-Fixing Deals Approved

A Pennsylvania federal court signed off on settlements ending price-fixing claims from direct purchasers against Sun Pharmaceutical Industries Inc. and Taro Pharmaceutical Industries USA Inc. in ongoing multidistrict litigation over generic drug prices.
February 27, 2023
Drugmakers To Face Price-Fixing Claims From State AGs

In a slew of rulings on Monday, a Pennsylvania federal court rejected most bids from drug companies seeking to nix sweeping price-fixing conspiracy allegations from a group of state attorneys general.
November 09, 2022
Drug Buyers, States Want To Depose Indicted Ex-Taro Exec

A group of drug purchasers and state-level enforcers accusing generic-drug manufacturers of fixing prices asked a Pennsylvania federal court on Tuesday to allow it to depose a former top executive who was indicted on criminal antitrust charges ahead of his trial.
June 07, 2022
AGs' Disgorgement Claim Axed In Drug Price-Fixing Case

The Pennsylvania federal judge overseeing sprawling price-fixing litigation against generic-drug makers on Tuesday tossed a disgorgement claim brought by state attorneys general, but kept alive their claim for injunctive relief.
May 25, 2022
Generic Distributors Slip Indirect Reseller Price-Fixing Claims

A Pennsylvania federal judge dismissed, for now, indirect generic-drug resellers' price-fixing claims levied against distributors like McKesson Corp. as a part of multidistrict litigation, ruling Wednesday that the plaintiffs failed to sufficiently allege a conspiracy.
May 20, 2022
Drugmakers Say Pa. AG Not Producing Generic-Drug Docs

Mylan and other pharmaceutical companies facing allegations of price-fixing for generic drugs told a Pennsylvania federal judge overseeing multidistrict litigation that the Pennsylvania Attorney General's Office has refused to produce key documents.

← Previous
…
3
4
5
6
7
8
9
10
11
…
Next →